Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease
Severe polypharmacy was initially present in more than 25% of older adults with IBD and increased to 34% within 4 years of the index visit. Severe polypharmacy, as well as PIM utilization among those with polypharmacy, were also associated with an increased risk of hospitalization at 1 year, highlighting the need for deprescribing efforts in this population.
Authors
- Mara McAdams‐DeMarco (ORCID: https://orcid.org/0000-0003-3013-925X)
- John A. Dodson (ORCID: https://orcid.org/0000-0003-0163-3013)
- William Schreiber-Stainthorp (ORCID: https://orcid.org/0000-0002-7386-8754)
- Darren Drittel (ORCID: https://orcid.org/0009-0003-3353-0235)
- Adam S. Faye (ORCID: https://orcid.org/0000-0002-1571-5856)
- Aasma Shaukat
- Dorry Lidor Segev (ORCID: https://orcid.org/0000-0002-1924-4801)
- Seymour Katz (ORCID: https://orcid.org/0000-0002-3492-9200)
- Olivia Delau
- Sakteesh Veerabadhran Gurunathan (ORCID: https://orcid.org/0000-0002-5524-370X)
- Joshua Chodosh (ORCID: https://orcid.org/0000-0001-7784-4306)
Institutions
- Thomas Jefferson University (US)
- NYU Langone Health (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2024-08-20
- DOI
- https://doi.org/10.14309/ajg.0000000000003036
- Citations
- 5
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 2.75